ARTICLE | Company News
Cortical inflammation news
December 19, 2011 8:00 AM UTC
Cortical hired Gerbsman Partners to manage a sale of all, or substantially all, of the company's assets. Corticol's macrophage migration inhibitory factor (MIF) inhibitors are in preclinical developm...